Why Non-Invasive Cardiovascular Diagnostics with CMAT Advantage Are the Future of Primary Care

Non-invasive cardiovascular diagnostics let primary-care practices evaluate peripheral arterial disease (PAD) and autonomic dysfunction during a standard office visit — no needles, no referral, and results in roughly 7–10 minutes. The CMAT Advantage system, built on the FDA 510(k)-cleared TM-Flow device, combines ankle-brachial index, pulse-volume recording, heart-rate variability, and sudomotor testing into one workflow — giving family physicians objective, billable data they would otherwise have to refer out for. Here is why non-invasive screening is becoming standard practice in primary care, and how CMAT Advantage fits a busy clinic.

1 | Primary Care Is Under Pressure to Evaluate Vascular Disease Earlier

• PAD prevalence is rising—current estimates hover near 20 million U.S. adults, yet half remain undiagnosed until symptomatic. PubMed (ACC/AHA Guidelines)
  
• 2024 ACC/AHA guidelines call for broader use of non-invasive testing (ABI ± adjunctive waveforms) in diabetics, smokers, and adults ≥ 65 years. PubMed (ACC/AHA Guidelines)
  
• Value-based contracts reward documented risk stratification, but manual Doppler workflows are slow and operator-dependent.
  

Take-home: Primary-care practices need a fast, reproducible way to screen PAD and autonomic dysfunction inside the standard visit length.

2 | How CMAT Advantage Expands Diagnostic Reach in 7 Minutes

One device, one MA, one sitting—three established CPTs.

3 | Clinical Snapshot for Busy Family Practices

Running 10 tests/week (50 weeks) at 2025 Medicare national averages:

Each code may be billable when the corresponding test is medically necessary and documented for a symptomatic or at-risk patient; coverage and amounts vary by payer.

4 | Why Non-Invasive Matters for Patient Experience & Quality Scores

1. Comfort & Speed – Automated cuffs and skin pads replace gel probes; the full protocol adds < 3 minutes beyond routine vitals.
   
2. Data-Driven Counseling – Color-coded PDF reports simplify shared-decision-making conversations.
   
3. MIPS & HEDIS Friendly – Objective PAD and autonomic data feed preventive-care and cardiometabolic quality measures.
   
4. Reducing Downstream Cost – Early detection prevents amputations and unplanned admissions—outcomes now tracked by many ACOs. pmc.ncbi.nlm.nih.gov
   

5 | Future-Proof Technology & Data Portability

• Secure software-update downloads add new analytics modules without new hardware.
  
• PDF reporting produces a report you can attach to the patient’s chart in the EHR, keeping vascular and autonomic findings in the complete patient record.
  
• Cloud audit logs satisfy IDTF and payer documentation rules. cms.gov
  

6 | Implementation Roadmap—Fast, Low-Friction

7 | Key Take-Aways for Primary-Care Leaders

• Guideline-Aligned: Meets 2024 ACC/AHA recommendations for PAD assessment.
• Triple-CPT Value: Elevates ancillary income without extra physician minutes.
• Patient-Centric: Non-invasive, fast, and education-friendly.
• Data-Portable: Structured, CPT-coded PDF reports attach to the patient’s EHR record and export cleanly for downstream analysis.
  

Ready to Evaluate the CMAT Advantage?

1. Download the clinical value Calculator to gauge impact with your payer mix.
2. Book a 30-minute live demo—see a triple-test run on de-identified patient data.
3. Request our due-diligence kit (clinical papers, warranty, financing) for partner review.
   

HealthWright Technologies Inc designed the CMAT Advantage so that every primary-care clinic can deliver hospital-grade cardiovascular insight—profitably, sustainably, and without a single needle stick.

Ready to get started? Learn how HealthWright Advantage bundles the device, training, and ongoing support your practice needs — backed by a 90-day buyback guarantee.

Frequently Asked Questions: Non-Invasive Cardiovascular Diagnostics in Primary Care

Why are non-invasive cardiovascular diagnostics important in primary care?

Non-invasive cardiovascular diagnostics let a primary-care team identify peripheral arterial disease (PAD) and autonomic dysfunction in at-risk and symptomatic patients — without sending the patient out for a referral. An estimated 20 million U.S. adults have PAD, and about half remain undiagnosed until they become symptomatic. The 2024 ACC/AHA guidelines specifically call for broader use of non-invasive testing in diabetics, smokers, and adults 65 and older.

Is the CMAT Advantage test FDA-cleared?

Yes. CMAT Advantage is built on the TM-Flow device, which holds FDA 510(k) clearance. (“FDA-cleared,” not “FDA-approved,” is the correct term for 510(k) devices.) You can review the FDA 510(k) device information for the specifics.

How much time does CMAT Advantage add to an office visit?

The complete test runs in about 7–10 minutes, and the full protocol adds less than three minutes beyond routine vitals. A medical assistant performs it in a single sitting using automated cuffs and skin sensors, so it fits inside a standard visit length.

Which CPT codes can a practice bill with CMAT Advantage?

CMAT Advantage supports three established CPT codes in one sitting: 93922 (ABI with pulse-volume recording), 95921 (autonomic heart-rate variability), and 95923 (sudomotor function), each separately billable when medically necessary and documented; coverage varies by payer.

How does CMAT Advantage support MIPS and HEDIS quality measures?

CMAT Advantage produces objective PAD and autonomic data that feed preventive-care and cardiometabolic quality measures, making it MIPS- and HEDIS-friendly. Color-coded PDF reports also support shared-decision-making conversations and the documentation that value-based contracts increasingly require.

Disclaimer: This article is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional for diagnosis, treatment, and clinical decision-making.

CPT codes are provided for informational purposes only and do not guarantee reimbursement. Verify code applicability and coverage with the relevant payer and your billing department before submitting claims. CPT® is a registered trademark of the American Medical Association.